José Marco-Contelles studied chemistry at the Universidad Complutense de Madrid, where he obtained the award of PhD in 1984. After post-doctoral stages at Institut de Chimie de Substance Naturelles (CNRS, Gif-sur-Yvette, France, 1984-85), Département de Chimie Organique (Université de Genève, Genève, Switzerland, 1986), and the Department of Chemistry (Duke University, Durham, US, 1988-89), in 2004 he was appointed as Senior Research Scientist at the IQOG (CSIC, Madrid, Spain). He has been Invited Professor at the Université Paris VI, Université Jules Verne-Picardie (Amiens, France), Okayama University (Okayama, Japan), and University of Franche-Comté (Besançon, France). He has lectured twice at Gordon Conferences, in 2001 (“Carbohydrates”), and 2004 (“Organic Reactions and Processes”). In 2002 he was awarded the French-Spanish award of the French Chemical Society. He has published more than 440 scientific contributions including Articles, Books, Journal issues as an Associated Editor, and Chapters in books. His interests include the design, synthesis, and biological evaluation of new ligands for Alzheimer’s disease, and stroke.
José Marco-Contelles studied chemistry at the Universidad Complutense de Madrid, where he obtained the award of PhD in 1984. After post-doctoral stages at Institut de Chimie de Substance Naturelles (CNRS, Gif-sur-Yvette, France, 1984-85), Département de Chimie Organique (Université de Genève, Genève, Switzerland, 1986), and the Department of Chemistry (Duke University, Durham, US, 1988-89), in 2004 he was appointed as Senior Research Scientist at the IQOG (CSIC, Madrid, Spain). He has been Invited Professor at the Université Paris VI, Université Jules Verne-Picardie (Amiens, France), Okayama University (Okayama, Japan), and University of Franche-Comté (Besançon, France). He has lectured twice at Gordon Conferences, in 2001 (“Carbohydrates”), and 2004 (“Organic Reactions and Processes”). In 2002 he was awarded the French-Spanish award of the French Chemical Society. He has published more than 440 scientific contributions including Articles, Books, Journal issues as an Associated Editor, and Chapters in books. His interests include the design, synthesis, and biological evaluation of new ligands for Alzheimer’s disease, and stroke.